• S1E2 - Ophthalmology Morning Commute: New Clinical Approaches and Sequencing of Age-Related Macular Degeneration Treatments

  • Jan 12 2024
  • Length: 22 mins
  • Podcast

S1E2 - Ophthalmology Morning Commute: New Clinical Approaches and Sequencing of Age-Related Macular Degeneration Treatments

  • Summary

  • In this episode, our faculty take a deeper dive into their discussion of treatments of neovascular AMD, including anti-VEGF agents and some of the newer agents, including a bispecific antibody that inhibits both VEGF and Ang2.

    Visit www.morningcommutepodcast.com/AMD2 to view the activity and CME/CE information, download the transcript, and complete the post-test and evaluation to earn CME/CE credit

    Show More Show Less
activate_samplebutton_t1

What listeners say about S1E2 - Ophthalmology Morning Commute: New Clinical Approaches and Sequencing of Age-Related Macular Degeneration Treatments

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.